Dr Darius Francescatti

Dr. Darius Francescatti serves on the Medical Advisory Board and has been instrumental in transforming cancer care through technological innovation. Rejecting the notion of ‘hope’ as a strategy, he aimed to provide clinicians and patients with an accurate, timely, and affordable predictive test for cancer recurrence, a major concern in post-operative care. Dr. Francescatti spearheaded the development of a new approach that combines infrared multi-spectral imaging (spectrometry) with artificial intelligence. This method not only reduces the subjectivity associated with traditional biomarker analysis but also delivers results much faster and at a significantly lower cost. His work creates new possibilities for personalized medicine and improves the decision-making process in cancer treatment, making advanced diagnostic tools more accessible and affordable.